SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-029919
Filing Date
2014-05-13
Accepted
2014-05-13 16:07:41
Documents
14
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v376739_10q.htm 10-Q 652841
2 EXHIBIT 10.1 v376739_ex10-1.htm EX-10.1 16386
3 EXHIBIT 10.2 v376739_ex10-2.htm EX-10.2 55733
4 EXHIBIT 10.3 v376739_ex10-3.htm EX-10.3 8407
5 EXHIBIT 31.1 v376739_ex31-1.htm EX-31.1 7058
6 EXHIBIT 31.2 v376739_ex31-2.htm EX-31.2 7066
7 EXHIBIT 32.1 v376739_ex32-1.htm EX-32.1 3243
8 EXHIBIT 32.2 v376739_ex32-2.htm EX-32.2 3218
  Complete submission text file 0001144204-14-029919.txt   6752635

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT bcli-20140331.xml EX-101.INS 1021230
10 XBRL TAXONOMY EXTENSION SCHEMA bcli-20140331.xsd EX-101.SCH 63697
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20140331_cal.xml EX-101.CAL 29682
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20140331_def.xml EX-101.DEF 251563
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20140331_lab.xml EX-101.LAB 368464
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20140331_pre.xml EX-101.PRE 282165
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54365 | Film No.: 14837369
SIC: 2836 Biological Products, (No Diagnostic Substances)